See what we’re reading this week at Global Biodefense on topics including regulation of genetically engineered livestock, chemical weapons investigators in Douma, and the latest news on rapid diagnostics. POLICY + INITIATIVES GAO asks [Read more]
See what we’re reading this week at Global Biodefense on topics including transnational biological threats, modernizing epidemiology, smallpox vaccine MVA, and drug-resistant typhoid outbreaks. POLICY + INITIATIVES NIAID research addressing biodefense and emerging and [Read more]
Researchers at Texas Biomedical Research Institute in San Antonio have been awarded a $2 million dollar contract by the makers of ZMapp, Mapp Biopharmaceutical, Inc., to further test this promising new therapeutic [Read more]
See what we’re reading this week at Global Biodefense on topics including the dangers of horsepox synthesis, portable biodosimetry systems, and improving vector-borne pathogen surveillance. SELECT AGENTS Horsepox Synthesis: A Case of [Read more]
A modeling study published last month in the Proceedings of the National Academies of Science suggests that human fleas and body lice–rather than rodents–may have caused a string of historical plague outbreaks [Read more]
Bavarian Nordic announced on Feb. 6 the results of a successful Phase 3 clinical trial led by the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) that demonstrated the safety and [Read more]
General Atomics Electromagnetic Systems (GA-EMS) has been awarded a contract from the Defense Advanced Research Projects Agency (DARPA) to develop a next generation Portable Diagnostic Platform for personnel to quickly self-perform testing [Read more]
The Department of Homeland Security (DHS) Science and Technology Directorate (S&T), in collaboration with the Office of Health Affairs National Biosurveillance Integration Center (NBIC), today announced five finalists for Stage 1 of the Hidden [Read more]
The etiological agent responsible for smallpox disease, Variola viridae (VARV) is responsible for the deaths of hundreds of millions of people throughout history. While smallpox disease is eradicated, repositories of VARV remain, [Read more]
Researchers from the University of Copenhagen and Phillips Universität Marburg have found a new target for inhibiting Ebola virus from copying itself to produce more infection in a host. ‘When the Ebola [Read more]
© 2018 Global Biodefense